GOG-3101 | TroFuse-20 Clinical Trial Update

GOG-3101 | TroFuse-20 Clinical Trial Update

In this episode, we dive into GOG‑3101 TroFuse‑20—a Phase 3, randomized, active‑controlled, open‑label, multicenter study evaluating MK‑2870 monotherapy versus Treatment of Physician’s Choice as second‑ or third‑line therapy for patients with recurrent or metastatic cervical cancer.

★ Support this podcast ★

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(22)

Populært innen Business og økonomi

stopp-verden
dine-penger-pengeradet
e24-podden
rss-penger-polser-og-politikk
rss-borsmorgen-okonominyhetene
rss-skravla-gar
rss-pa-konto
livet-pa-veien-med-jan-erik-larssen
pengepodden-2
tid-er-penger-en-podcast-med-peter-warren
utbytte
lederpodden
finansredaksjonen
stormkast-med-valebrokk-stordalen
rss-markedspuls-2
morgenkaffen-med-finansavisen
pengesnakk
rss-orjasater
okonomiamatorene
rss-fa-makro